21 CFR 350.60
§ 350.60 Guidelines for effectiveness testing of antiperspirant drug products.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 350.60, § 350.60 Guidelines for effectiveness testing of antiperspirant drug products, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86679
- Permanent ID
ys:prov:86679@1- SHA-256
2fc95952cf35668514e0ca5466d8b88b2531d865ec48fe391a36d8d9e9a33531
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
An antiperspirant in finished dosage form may vary in degree of effectiveness because of minor variations in formulation. To assure the effectiveness of an antiperspirant, the Food and Drug Administration is providing guidelines that manufacturers may use in testing for effectiveness. These guidelines are on file in the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. These guidelines are available on the FDA's web site at http://www.fda.gov/cder/otc/index.htm or on request for a nominal charge by submitting a Freedom of Information (FOI) request in writing to FDA's Division of Freedom of Information (address is located on the agency's web site at http://www.fda.gov.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.